
Investments
457Portfolio Exits
100Funds
3Partners & Customers
2About Samsung Ventures
Samsung Ventures was established to promote the establishment of small and medium-sized companies engaging in developing technologies. Samsung's major investment areas include semiconductor, telecommunication, software, Internet, bioengineering and medical, and film/video industries, while potential investment subjects range from start-ups to established companies that are about to be listed in the stock market. As an investor, Samsung aims to provide investment funds as well as management support, technical support and market registration to the companies it invests in.

Want to inform investors similar to Samsung Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Samsung Ventures
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Samsung Ventures in 5 Expert Collections, including AR/VR.
AR/VR
33 items
HR Tech
65 items
Unicorns- Billion Dollar Startups
115 items
Fitness Tech
227 items
We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.
Digital Lending
34 items
This collection contains alternative means for obtaining a loan for personal or business use. Companies included in the application, underwriting, funding, or collection process is included in the collection.
Research containing Samsung Ventures
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Samsung Ventures in 1 CB Insights research brief, most recently on Dec 9, 2021.
Latest Samsung Ventures News
Apr 25, 2023
1 Samsung Ventures has made a strategic investment in Araris Biotech. The investment corporation, that was established to promote the development of new technologies, has invested in the company in an independent deal ahead of its on-going series A funding. The investment was made via Samsung Life Science Fund which reflects Samsung’s commitment to further explore and expand various business opportunities in biopharmaceuticals. Araris Biotech, a company pioneering antibody-drug conjugate (ADC) linker technology, intends to use the proceeds to support further development and advancement of Araris’ antibody-drug conjugate (ADC) candidates. BGPartner assisted Araris Biotech in the negotiations and advised on all Swiss legal matters regarding this strategic investment. The team was led by partner Oliver Gnehm (pictured left) and further consisted of Thomas Gysin (senior associate, pictured right).
Samsung Ventures Investments
457 Investments
Samsung Ventures has made 457 investments. Their latest investment was in Araris Biotech as part of their Series A - III on April 4, 2023.

Samsung Ventures Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
4/11/2023 | Series A - III | Araris Biotech | Yes | 1 | ||
3/21/2023 | Series A - II | Neubility | $2.29M | No | 8 | |
2/23/2023 | Bridge | Let's go baby | Yes | 1 | ||
2/22/2023 | Series B - II | |||||
2/21/2023 | Series A |
Date | 4/11/2023 | 3/21/2023 | 2/23/2023 | 2/22/2023 | 2/21/2023 |
---|---|---|---|---|---|
Round | Series A - III | Series A - II | Bridge | Series B - II | Series A |
Company | Araris Biotech | Neubility | Let's go baby | ||
Amount | $2.29M | ||||
New? | Yes | No | Yes | ||
Co-Investors | |||||
Sources | 1 | 8 | 1 |
Samsung Ventures Portfolio Exits
100 Portfolio Exits
Samsung Ventures has 100 portfolio exits. Their latest portfolio exit was Autotalks on May 08, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/8/2023 | Acquired | 11 | |||
3/6/2023 | Acquired | 1 | |||
1/23/2023 | Acquired | 21 | |||
Date | 5/8/2023 | 3/6/2023 | 1/23/2023 | ||
---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 11 | 1 | 21 |
Samsung Ventures Fund History
3 Fund Histories
Samsung Ventures has 3 funds, including Automotive Innovation Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/14/2017 | Automotive Innovation Fund | $300M | 1 | ||
5/29/2014 | Samsung Wearable Health Fund | ||||
2/4/2013 | Samsung Catalyst Fund |
Closing Date | 9/14/2017 | 5/29/2014 | 2/4/2013 |
---|---|---|---|
Fund | Automotive Innovation Fund | Samsung Wearable Health Fund | Samsung Catalyst Fund |
Fund Type | |||
Status | |||
Amount | $300M | ||
Sources | 1 |
Samsung Ventures Partners & Customers
2 Partners and customers
Samsung Ventures has 2 strategic partners and customers. Samsung Ventures recently partnered with DeepMotion on March 3, 2019.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
3/6/2019 | Partner | China | DeepMotion launches digital avatars for Samsung’s Galaxy S10 smartphones `` Body language is a key part of human social interaction , and our partnership with Samsung Ventures empowers Galaxy S10 owners to use their natural body movements to express themselves through emojis , '' said Kevin He , CEO of DeepMotion , in a statement . | 1 | |
1/6/2014 | Partner |
Date | 3/6/2019 | 1/6/2014 |
---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | China | |
News Snippet | DeepMotion launches digital avatars for Samsung’s Galaxy S10 smartphones `` Body language is a key part of human social interaction , and our partnership with Samsung Ventures empowers Galaxy S10 owners to use their natural body movements to express themselves through emojis , '' said Kevin He , CEO of DeepMotion , in a statement . | |
Sources | 1 |
Samsung Ventures Team
12 Team Members
Samsung Ventures has 12 team members, including current Chief Executive Officer, President, Youngjoon Choi.
Name | Work History | Title | Status |
---|---|---|---|
Youngjoon Choi | Chief Executive Officer, President | Current | |
Name | Youngjoon Choi | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer, President | ||||
Status | Current |
Compare Samsung Ventures to Competitors

Pfister Energy is a company dedicated to Renewable Energy solutions.nAs part of their plan to save money, save energy, create public goodwill and sleep better each night, Pfister Energy creates "Green solutions" that make sense for commercial, industrial and institutional properties:nn * Solarn * Daylightingn * Building Envelope Improvementsn * Wind Turbinesn * Solar Lighting (paths and parking lots)nnPfister Energy is committed to applying the latest technologies in Renewable Energy so that users reap the benefits of a energy-efficient solution:nn * Financial savings and ROIn * Energy savingsn * Public stewardship and goodwilln * Emissions reductionsn * Environmental leadership andn * Energy independencennDesign-BuildnEach Pfister Energy system includes a financial feasibility study, technical or engineering study and strategic project description including timelines, costs and responsibility. Building construction, seasonal solar exposures and budgets are always wide-ranging so the company spend extra time selecting and integrating the right Renewable Energy solution to meet their goals. As a "Design-Build" contractor, the company provide turnkey solutions that include design, procurement, installation, commission and maintenance directly to clients, architects, and even other solar design firms! The company have the personnel and equipment that it takes to each job so there is no need for subcontractors. FinancingnAs part of all Renewable Energy projects, Pfister Energy includes the financial impact of state and federal rebates, government tax incentives and management of Renewable Energy Certificates to maximize their investment. The company also offer project financing and leasing if needed. Going Green may take less "Green" than users think!nnExperiencenPfister Energy is a division of Pfister Industries, Inc, a provider of commercial roofing, construction and waterproofing for almost 25 years. The company's experience on the top of buildings aims to allow us to present a project that blends in with existing physical components and systems. With Pfister Energy, users can be sure that the addition of any energy-saving service will preserve if not enhance their existing building's integrity. Even existing roof warranties can be honored!nnBeliefsnThe company live the life! Every day the company understand more about the company's obligation to protect the natural resources and life the company love. The company's challenge is to balance this knowledge and responsibility with the expectations of business and industry today. Pfister Energy is committed to offering Green solutions to the company's employees and applying technologies to the company's own properties. The company welcome users as a Renewable Energy customer and environmental steward!
Description from the About/Overview section: Solaris' primary aims to provide low manufacturing cost, high efficiency and long life solar cells to capture a major portion of the projected growth of the global renewable energy market. Equity financing and Company resources are used exclusively towards this goal. However, since Solaris' NanoAntennaTM materials present a number of other large market opportunities which are validated in part by the development of high efficiency photovoltaics, the company have begun to pursue these other applications through externally funded collaborations, contracts, and agreements. These other applications of the company's nano-antenna technology and intellectual property include the enhancement of human vision, high performance liquid crystal displays, and chemical and biological sensing. Solaris Nanosciences is a subsidiary of Spectra Systems Corporation (www.spsy.com), a profitable, private company spun out of Brown University in 1996. Spectra Systems' core competence in high performance optical materials, intellectual property and physical infrastructure led to the launch of Solaris Nanosciences in May of 2004.
J. Lamarck is a company that offers advisory services to private individuals, companies and pension funds who want to invest in the biotechnology sector.nThe company offers a high quality service and its analyst provide professional assistance to people who want to diversify a part of their portfolio in this emerging industry. Because of the nature of biotechnology investments, the company believe it is important that users work with specialists to define their portfolio strategy. Generally, specialists do things better.nOver the next few years the company will be witness of astonishing progress in health care and medicine, the company will be able to fight and cure diseases like AIDS and cancer finally. The company will also find solutions to clean up the environment and new crops that don't need pesticide. These new products will obviously boost the visibility of the companies that were at the beginning of this process on the stock market and consequently create great opportunity for it's shareholders.nJ. Lamarck wants to be their partner in this great venture.

Punjab Biotechnology Incubator (PBTI) welcomes users to its state-of-the- art Agri & Food Testing Laboratory set up at SAS Nagar (Mohali), the hub of Biotechnology and Information Technology in Punjab. PBTI is a State Govt. Undertaking registered as a "˜Society for Biotechnology Incubator' under the Society Registration Act 1961 and is professionally governed by Governing Council of the Society under the chairmanship of Chief Secretary, Govt. of Punjab. The day to day affairs are managed by Chief Executive Officer, supported by technical professionals of high caliber.

Blaze Systems is a provider of total LIMS software solutions for the laboratory marketplace.
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.